初诊Ⅳ期乳腺癌的局部治疗研究进展

doi:10.11904/j.issn.1002-3070.2019.06.020

实用肿瘤学杂志 ›› 2019, Vol. 33 ›› Issue (6): 575-578.doi: 10.11904/j.issn.1002-3070.2019.06.020

• 综述 • 上一篇

初诊Ⅳ期乳腺癌的局部治疗研究进展

沈依哲综述, 郭宝良审校

哈尔滨医科大学附属第二医院乳腺外科(哈尔滨 150081)

收稿日期:2019-03-12 修回日期:2019-04-01 发布日期:2019-12-28
通讯作者: 郭宝良,E-mail:baoliangguo@aliyun.com
作者简介:沈依哲,女,(1993-),硕士研究生,从事乳腺外科的研究。

Progress in local treatment of newly diagnosed stage IV breast cancer

SHEN Yizhe, GUO Baoliang

Department of Breast Surgery,Second Affiliated Hospital of Harbin Medical University,Harbin 150081,China

Received:2019-03-12 Revised:2019-04-01 Published:2019-12-28

摘要/Abstract

摘要： 转移性乳腺癌(Metastatic breast cancer,MBC)是一种难以治愈性疾病,得益于全身治疗的发展和普及,患者整体预后已得到显著改善。而初诊Ⅳ期乳腺癌(De novo stage IV breast cancer)原发灶、转移灶的手术切除能否在系统治疗的基础上带来生存获益,目前存在较大争议,需要结合病人具体情况给予个体化诊治。现就初诊Ⅳ期乳腺癌外科治疗领域的热点问题进行综述。

关键词: 初诊Ⅳ期乳腺癌, 寡转移, 系统治疗, 外科干预, 转移性乳腺癌

Abstract: Metastatic breast cancer(metastatic breast cancer,MBC)is a difficult-to-cure disease.However,its overall prognosis of patients has been improved significantly with the development and spread of systemic treatment.Whether the surgical resection of primary or metastatic foci of the first stage IV breast cancer(De novo stage IV breast cancer)can bring survival benefits on the basis of systemic treatment is currently controversial,and needs to be combined with the specific circumstances of the patient,individualized diagnosis and treatment.This paper reviews the hot issues in the field of surgical treatment for newly diagnosed stage IV breast cancer.

Key words: De novo stage IV breast cancer, Oligometastasis, Systemic therapy, Surgical intervention, Metastatic breast cancer

中图分类号:

R737.9

沈依哲, 郭宝良. 初诊Ⅳ期乳腺癌的局部治疗研究进展[J]. 实用肿瘤学杂志, 2019, 33(6): 575-578.

SHEN Yizhe, GUO Baoliang. Progress in local treatment of newly diagnosed stage IV breast cancer[J]. Journal of Practical Oncology, 2019, 33(6): 575-578.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2019.06.020

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2019/V33/I6/575

参考文献

1 Lane WO,Thomas SM,Blitzblau RC,et al.Surgical resection of the primary tumor in women with de novo stage IV breast cancer:contemporary practice patterns and survival analysis[J].Ann Surg,2019,269(3):537-544.
2 Siegel RL,Miller KD,Jemal A.Cancer statistics for Hispanics/Latinos,2018[J].CA Cancer J Clin,2018,68(6):425-445.
3 Thomas A,Khan SA,Chrischilles EA,et al.Initial surgery and survival in stage IV breast cancer in the United States,1988-2011[J].JAMA Surg,2016,151(5):424-431.
4 Mariotto AB,Etzioni R,Hurlbert M,et al.Estimation of the number of women living with metastatic breast cancer in the United States[J].Cancer Epidemiol Biomarkers Prev,2017,26(6):809-815.
5 Pagani O,Senkus E,Wood W,et al.International guidelines for management of metastatic breast cancer:can metastatic breast cancer be cured?[J].J Natl Cancer Inst,2010,102(7):456-463.
6 Cardoso F,Costa A,Senkus E,et al.3rd ESO-ESMO international consensus guidelines for advanced breast cancer(ABC 3)[J].Ann Oncol,2017,28(12):3111.
7 Wuerstlein R,Ettl J,Haidinger R,et al.Highlights from ABC4-bridging the gap[J].Breast Care(Basel),2017,12(6):415-419.
8 McAnena PF,McGuire A,Ramli A,et al.Breast cancer subtype discordance:impact on post-recurrence survival and potential treatment options[J].BMC Cancer,2018,18(1):203.
9 Abbasi-Malati Z,Roushandeh AM,Kuwahara Y,et al.Mesenchymal stem cells on horizon:a new arsenal of the rapeutic agents[J].Stem Cell Rev,2018,14(4):484-499.
10 Yeung C,Hilton J,Clemons M,et al.Estrogen,progesterone,and HER2/neu receptor discordance between primary and metastatic breast tumours-a review[J].Cancer Metastasis Rev,2016,35(3):427-437.
11 Karnoub AE,Dash AB,Vo AP,et al.Mesenchymal stem cells within tumour stroma promote breast cancer metastasis[J].Nature,2007,449(7162):557-563.
12 Bourgier C,Khodari W,Vataire AL,et al.Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease[J].Radiother Oncol,2010,96(2):199-203.
13 Palma DA,Salama JK,Lo SS,et al.The oligometastatic state-separating truth from wishful thining[J].Nat Rev Clin Oncol,2014,11(9):549-557.
14 Tsalis K1,Ioannidis O,Cheva A,et al.A 20-year single center experience in the surgical treatment of colorectal liver metastasis[J].J BUON,2018,23(6):1640-1647.
15 Yoo TK,Chae BJ,Kim SJ,et al.Identifying long-term survivors among metastatic breast cancer patients undergoing primary tumor surgery[J].Breast Cancer Res Treat,2017,165(1):109-118.
16 Muzaffar M,Kachare S,Vohra N.Impact of primary tumor surgery in stage IV male breast cancer[J].Clin Breast Cancer,2017,17(3):143-149.
17 Choi SH,Kim JW,Choi J,et al.Locoregional treatment of the primary tumor in patients with de novo stage IV breast cancer:a radiation oncologist′s perspective[J].Clin Breast Cancer,2018,18(2):167-178.
18 Badwe R,Hawaldar R,Nair N,et al.Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer:an open-label randomised controlled trial[J].Lancet Oncol,2015,16(13):1380-1388.
19 Soran A,Ozmen V,Ozbas S,et al.Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation:protocol MF07-01[J].Ann Surg Oncol,2018,25(11):3141-3149.
20 King TA,Lyman JP,Gonen M,et al.A prospective analysis of surgery and survival in stage IV breast cancer(TBCRC 013)[J].J Clin Oncol,2016,34(20):2359-2365.
21 Fornetti J,Welm AL,Stewart SA,et al.Understanding the bone in cancer metastasis[J].J Bone Miner Res,2018,33(12):2099-2113.
22 Friedel G,Pastorino U,Ginsberg RJ,et al.Results of lung metastasectomy from breast cancer:prognostic criteria on the basis of 467 cases of the international registry of lung metastases[J].Eur J Cardiothorac Surg,2002,22(3):335-344.
23 Pockaj BA,Wasif N,Dueck AC,et al.Metastasectomy and surgical resection of the primary tumour in patients with stage IV breast cancer:time for a second look?[J].Ann Surg Oncol,2010,17(9):2419-2426.
24 Kycler W,Laski P.Surgical approach to pulmonary metastases from breast cancer[J].Breast J,2012,18(1):52-57.
25 Mimoto R,Kobayashi T,Imawari Y,et al.Clinical relevance and low tumour-initiating properties of oligometastatic breast cancer in pulmonary metastasec-tomy[J].Breast Cancer Res Treat,2014,147(2):317-324.
26 Fan J,Chen D,Du H,et al.Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients:a systematic review and meta-analysis[J].J Thorac Dis,2015,7(8):1441-1451.
27 Pagani O,Senkus E,Wood W,et al.International guidelines for management of metastatic breast cancer:can metastatic breast cancer be cured?[J].J Natl Cancer Inst,2010,102(7):456-463.
28 Ye T,Yang B,Tong H,et al.Long-term outcomes of surgical resection for liver metastasis from breast cancer[J].Hepatogastroenterology,2015,62(139):688-692.
29 Margonis GA,Buettner S,Sasaki K,et al.The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer:a multi-institutional analysis[J].HPB(Oxford),2016,18(8):700-705.
30 Ercolani G,Zanello M,Serenari M,et al.Ten-year survival after liver resection for breast metastases:a single-center experience[J].Dig Surg,2018,35(4):372-380.
31 Abbott DE,Brouquet A,Mittendorf EA,et al.Resection of liver metastases from breast cancer:estrogen receptor status and response to chemotherapy before metastasectomy define outcome[J].Surgery,2012,151(1):710-716.
32 靳团,张清媛.乳腺癌脑转移的信号通路和分子机制的研究进展[J].实用肿瘤学杂志,2017,31(5):468-471.

[1]	马焱, 何红, 王赛男. 多西他赛解救治疗不同年龄组转移性乳腺癌的临床研究[J]. 实用肿瘤学杂志, 2019, 33(4): 352-356.
[2]	杜夜生, 胡松柳, 徐向英. 非小细胞肺癌寡转移的立体定向放射治疗研究[J]. 实用肿瘤学杂志, 2018, 32(2): 154-158.
[3]	蔡莉, 宋晓薇, 潘丽华, 石光跃, 刘炜, 孙立春, 陈雪松, 赵丽娜. 探讨循环肿瘤细胞的上皮间质转化基因Twist对晚期乳腺癌化疗疗效的影响[J]. 实用肿瘤学杂志, 2013, 27(1): 37-41.
[4]	孙艳丽;卢振霞;王立波. 长春瑞滨联合卡培他滨治疗转移性乳腺癌30例临床观察[J]. 实用肿瘤学杂志, 2005, 19(01): 9-11.

初诊Ⅳ期乳腺癌的局部治疗研究进展

Progress in local treatment of newly diagnosed stage IV breast cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

本文评价